The role of glycosaminoglycans or mucopolysaccharides as a possible constituent in amyloid was suggested by Oddi in 1894.9 Investigations undertaken by Bitter and Muir in 1966 further suggested that heparan sulphate could be involved in the deposition of protein in insoluble fibrillar form in the amyloid lesions."'t
The water extraction method of Pras and coworkers has become the standard method for isolation of amyloid fibrils from affected tissues."
We used this method to investigate the possible association of glycosaminoglycans with AA type human amyloid fibrils.
Materials and methods

SOURCE OF AMYLOID FIBRILS
Protein AA type amyloid fibrils were prepared from the liver of a 12 year old male patient, who had amyloidosis associated with juvenile rheumatoid arthritis. The 13 Antisera to AA, AL, and prealbumin related amyloid were produced in rabbits by immunisation with amyloid fibrils degraded with 0* 1 M NaOH and absorbed as previously described.14 ISOLATION OF GLYCOSAMINOGLYCANS Lyophilised amyloid fibrils were dissolved (6 mg/ml) in 0-2 M trometamol HCI pH 8-0 and digested with pronase 0-2 mg/ml at 36°C for 18 hours. The digested fibrils and the digest from the corresponding extract of the normal liver were chromatographed on a diethylaminoethyl (DEAE)-Sephacel ion exchange column. 15 The column was eluted with 0*05 M sodium acetate buffer pH 4-0 with a gradient from 02 M NaCI to 2-0 M NaCI. Selected fractions were pooled after determination of hexuronic acid, dialysed against distilled water, and lyophilised.
The lyophilised polysaccharide fractions were dissolved in 05 ml phosphate buffered saline pH 7-3.
CARBAZOLE REACTION
Hexuronic acid was determined by the carbazole method described by Bitter and Muir16 with glucuronolactone as standard. Figure 1 shows the elution profile of carbazole reactive polysaccharides obtained by gradient ion exchange chromatography of amyloid fibrils from the patient after treatment with pronase. One small and three larger peaks were obtained at molarities of 0*60 (peak 1), 0 73 (peak 2), 0-80 (peak 3), and 0-93 (peak 4). This pattern was consistent throughout several runs on DEAE-Sephacel. Table 1 shows the quantities of carbazole positive polysaccharides eluted in the various peaks. More than half of the polysaccharides was eluted at 0-73 M NaCl (peak 2), but a considerable amount (approximately 20%) was eluted in the position corresponding to the peak of a heparin standard, indicating a relatively high degree of sulphation or large molecular size of the polysaccharide associated with amyloid fibrils, or both (Fig. 1) .
The total amount of such polysaccharides coisolated with amyloid fibrils extracted in the second water supernatant was approximately 15 ,ug/mg of lyophilised fibrils (Table 1) . A corresponding extract from normal human liver yielded only trace amounts of carbazole positive polysaccharides after ion exchange chromatography and showed virtually no peaks corresponding to those of the amyloid material (Fig. 1) .
ENZYMATIC CHARACTERISATION OF AMYLOID ASSOCIATED GLYCOSAMINOGLYCANS
Separate samples of the amyloid associated polysaccharide material obtained from the four ion exchange chromatography peaks ( Fig. 1) were subjected to heparitinase and to sequential treatment with chondroitinase AC and chondroitinase ABC. Table 2 shows the relative amounts of degradable material using the respective enzymes.
The glycosaminoglycans which are degraded by chondroitinase AC and chondroitinase ABC represent chondroitin sulphate and dermatan sulphate, and more than 60% of the total polysaccharides is accounted for by these glycosaminoglycans. In peaks 3 heparin/heparan sulphate was found in the ion exchange chromatography peak 2 ( Fig. 1) , containing 55% of the total content of carbazole positive material (Table 1) In the present work we confirmed the specific association of polysaccharides with AA type, human hepatic amyloid. Using the standard method for purification of amyloid fibrils1' we have shown here that significant amounts of polysaccharide are coisolated with such fibrils. The evidence for this is as follows: (a) The purification procedure for amyloid fibrils'1 involves several washings of homogenised tissue with physiological saline before the extraction of amyloid fibrils with water. The polysaccharides were specifically coisolated with the water extracted hepatic amyloid fibrils and not with the corresponding extract from normal liver. (b) Carbazole positive polysaccharide material was obtained by ion exchange chromatography at elution positions characteristic of glycosaminoglycans.'5 (c) The treatment of the polysaccharides derived from amyloid fibril with specific enzymes provided direct biochemical proof of their identity as glycosaminoglycans.
It appears, therefore, that glycosaminoglycans are integrated in or intimately associated with human AA type amyloid fibrils. This is compatible with the histochemical and structural observations by Snow and coworkers, who showed a close association between glycosaminoglycans and splenic AA type amyloid fibrils in mice. 26 The composition of glycosaminoglycans in amyloid deposits may vary with different clinical and chemical types of amyloidosis, age of the affected individual, disease duration, and organs or tissues involved. This possibility is being studied further.
The role of glycosaminoglycans in the formation of amyloid fibrils has not been established. The highly negatively charged glycosaminoglycan chains may be involved in protein folding and thus in the formation of fibrils.27 It has also been suggested that glycosaminoglycans may modulate the fibril formation of other proteins, like collagen.28 Furthermore, it has recently been suggested that glycosaminoglycans may be part of the so called amyloid enhancing factor.29 30 This factor is poorly defined but appears to consist of both polysaccharide and protein. 29 Amyloid enhancing factor activity is present in highly purified amyloid fibrils30 and has been shown to accelerate considerably the formation of AA experimental amyloid.31 Amyloid enhancing factor activity has been observed in tissue extracts from AA, AL, and prealbumin related amyloidosis. 32 If it is assumed that glycosaminoglycans are essential for amyloid enhancing factor activity then polyanionic sugars may be a significant constituent common to amyloids of different protein composition. The striking ultrastructural homology of amyloid fibrils having such diverse protein structure may thus be caused by the presence of glycosaminoglycans as their 'common denominator'. 
